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Zika virus (ZIKV) was discovered more than half a century ago, recently it has gained
unprecedented attention by the global health community. Until 2007, only 14 cases of
human ZIKV infections were reported around the globe, while during the current
outbreak, estimated cases mounted to approximately 1.5 million in Brazil alone, the virus
was disseminated to wider South-American territories and travel-associated ZIKV in-
fections were reported in USA, Europe and recently in China. ZIKV infections remain
asymptomatic in approximately 80% of the individuals, and no anti-viral treatments were
recommended. Yet, neurological complications associated with the infections, such as
infant microcephaly and Guillain–Barre´ syndrome are major cause of the concern.
Although, based on small numbers of cases, existing evidence strongly supports an
exclusive link of viral infection and observed neurological complications. However,
much work remains to assign exact numbers of complications caused by ZIKV.
Regarding its structural attributes ZIKV shows remarkable resemblance with dengue
virus and West-Nile virus. Despite, genomes of different ZIKV strains have already been
decoded; role of the viral components in infection process and particularly pathogenesis
of the disease remain widely unclear. In vulnerable areas, most viable strategy to ensure
public health safety is vector control and enhanced public awareness about the trans-
mission of the disease.1. Introduction
In year 1881, Carlos Juan Finlay, world renowned Spanish-
Cuban physician, presented the concept of yellow fever trans-
mission by mosquito bite [1]. Later on, in the year 1901, it was
proven by Walter Reed and colleagues. Yellow fever virus was
the ﬁrst to be identiﬁed among Arboviruses in year 1907 and the
dengue fever virus was identiﬁed as second such virus.
Transmission of dengue fever was explained by John Burton
Cleland and Joseph Franklin Siler [2]. Among arboviruses,
except, African-Swine fever virus that belongs to Asfarviridae,
all clinically important viruses are classiﬁed into four families:
Bunyaviridaes, Flaviviridae, Reoviridae and Togaviridae [3].
Zika virus (ZIKV) is an Arbovirus which belongs to the
family Flaviviridae and phylogenetically, it relates to Spondweni
virus, originally found in sub-Saharan Africa, and Papua New
Guinea. The name ‘ZIKA’ originates from Zika forest locatednear the Lake Victoria in Uganda. First scientiﬁc report about
ZIKV was published in 1947 [4]. A year later virus was isolated
from Aedes africanus, a mosquito species indigenous to that
region [4]. Subsequently, several reports conﬁrmed prevalence
of ZIKV in Nigeria, Sierra Leone, Gabon, Uganda, Central
African Republic and Coˆte d'Ivoire [5–12]. Presence was
conﬁrmed in several Asian-countries including Cambodia,
Indonesia, Malaysia, Micronesia and Pakistan [13–17]. Despite
these earlier published reports, virus gained signiﬁcant
attention only in year 2007, after an outbreak on Yap Island
[15,18,19]. Prior to this outbreak, only 14 cases of human
infections were reported. In year 2013, an outbreak of ZIKV
occurred in French Polynesia, which was accompanied by
dengue epidemic and during this outbreak, for the ﬁrst time
malformations such as Guillain–Barre´ Syndrome (GBS) and
microcephaly were reported in the patients [20]. Another
unique aspect of this outbreak was dissemination of virus
outside the African and Asian regions. In 2016, ZIKV was
reported in more than 28 countries with highest numbers of
infections in Brazil. The current outbreak in Brazil started
during the month of April, in year 2015. The city named
‘Natal’ located in the state of Rio Grande do Norte inicense (http://
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Soon after, virus disseminated across the country and frequent
reports of microcephaly coincided with ZIKV infections [20,22].
Moreover, several cases of miscarriages and stillbirths were
also reported. According to the recent estimates, total numbers
of ZIKV cases during this outbreak may surpass 1.5 million. It
was the largest outbreak recorded in human history and
became a reason for public health emergency in Brazil [21].
2. Structure and genome
The ZIKV virion shows icosahedral symmetry of its nucle-
ocapsid which is approximately (50–60) nm in size [23–26].
Recently, cryoelectron microscopic structure of the mature
ZIKV was elucidated, that reﬂects structural similarities with
other members of the Flaviviridae, including dengue virus
(DENV) and West-Nile virus [26]. Virus carries a positive-
sensed RNA of approximately, 11 kb in size with an estimated
mutation rate up to 12 to 25 bases per year [27–29]. The
architecture of the genome reveals two ﬂanking regions, which
are non-coding and are known as 50 and 30 NCR regions [29].
Apart from these two regions, rest of the genome is translated
as a single open-reading frame encoding a polyprotein that is
processed to make C-protein, encoding capsid, prM-protein, a
precursor of membrane, E-protein, encoding envelop and seven
other non-structural molecules known as NS-proteins [29]. A
53 kDa, E-protein of the virus plays a key role in binding and
membrane fusion process [30,31]. The largest protein encoded
by ZIKV is NS5 (z103 kDa), a multifunctional molecule, its
C-terminal confers, RNA-dependent RNA polymerase activity,
while N-terminus carries methyl transferase activity that medi-
ates RNA capping [29]. Function of the remaining NS-proteins
remains unknown. The role of 30 NCR region of the ZIKV
genome has been postulated in recognition of cellular and viral
factors, translation process, genome stabilization and RNA
packaging [29]. First full genome sequence of ZIKV has been
reported in 2007 [30]. Till to date, other than few studies, not
much is known about the evolutionary dimensions of ZIKV
strains [32]. Based on 43 viral strains collected over the period
of 60 years (from 1947 to 2007) revealed three major clusters
of strains which were spread across African and Asian
regions, all originated from common ancestral lineage [32].
Moreover, a recent phylogenetic study, in Brazil, endorses
origin of all isolates to common ancestor, identiﬁed as ZIKV
strain of French Polynesia. In addition, it was also conﬁrmed
that viral spread occurred from Paciﬁc island to Brazil during
second half of the year 2013.
3. Vectors and transmission
Both Aedes and Culex, mosquito species are common
inhabitant of Zika forest [33]. Aedes aegypti (A. aegypti), is
known as predominant vector for the transmission of both
DENV [34] and ZIKV. It originated in African region and
was descended from a zoophilic tree hole mosquito species
known as A. aegypti formosus. Hypothetically described, A.
aegypti was introduced to the new world by slave trade and
later it disseminated to distant the geographical regions
including tropical and sub-tropical areas [35]. Unlike A.
aegypti, second important vector of ZIKV, Aedes albopictus
is a zoophilic forest mosquito which originated from Asia.Over the time, it was also spread across different islands in
Indian and Paciﬁc Ocean [36] and further disseminated
across Europe, the United States and Brazil [37,38].
Currently, both mosquito species are persistent across wider
Asian and American territories [39]. Obviously, dissemination
of these mosquito species has a great inﬂuence on public
health around the globe [40–42]. For example, DENV alone
is estimated to cause 100 million symptomatic infections
each year, while every second person in the world is at the
risk of developing DENV infection [40,41]. Epidemiological
patterns of these two important arboviruses suggest that in
the future, ZIKV may cause other outbreaks, particularly in
the areas of high vector concentration. Before the recent
outbreak of ZIKV in Brazil, distribution of A. aegypti and
Aedes albopictus was predicted across different continents
[43] and based on the available entomological data, it was
shown that American region particularly Brazil has the
highest reported occurrence rates for both ZIKV vectors [43].
Thus, higher concentration of these vector species in Brazil
might be one reason for the current outbreak of this
magnitude and as well for the rapid dissemination of ZIKV
infection across the country. Other potential vectors for
ZIKV include Aedes furcifer, Aedes vittatus, Aedes dalzieli,
Aedes metallicus, Aedes hirsutus, Aedes unilinaetus, Aedes
africanus, Aedes taylori, Aedes hensillican and Aedes
luteocephalus.
Other than mosquito-borne transmission perinatal and sexual
transmissions of the virus were also reported [44,45]. First
incidence of sexual transmission was recorded in year 2008,
while during the current outbreak multiple cases of sexual
transmission were witnessed, latest in France [46]. In year
2013, in French Polynesia, presence of ZIKV nucleic acid was
conﬁrmed among 2.8% of the asymptomatic blood donors and
transfusion transmitted infection was reported recently [47].
4. General clinical manifestations and laboratory
diagnostic
Majority of the ZIKV infections remain asymptomatic and
less than 20% of the infected individuals show symptoms which
include but are not limited to fever, maculopapular rash,
conjunctivitis and arthralgia. Hence, asymptomatic infections
may remain unnoticed. Incubation period for the virus is sug-
gested to be (3–12) d while the course of infection may extend
up to (2–7) d, which is mostly self-limiting. However, persons
exposed to secondary infections of dengue fever virus may
experience severe form of the infection. During symptomatic
episode of the infection, several laboratory parameters and
symptoms may help to indicate ZIKV infection, as for example,
leukopenia, thrombocytopenia, serum lactate dehydrogenase,
gamma-glutamyl transferase and elevated protein markers
(including C-reactive protein, ﬁbrinogen and ferritin) are
noticed. One of the most important challenges regarding detec-
tion of the virus in patient's samples is lack of sensitive and
speciﬁc laboratory test. Unfortunately, previously reported tests
show serious cross-reactivity and are difﬁcult to perform [48–50].
Although, PCR based testing of saliva, blood and urine is highly
recommended, availability of the desired amount of nucleic acid
in different body ﬂuids remains as signiﬁcant hindrance (50). To
date, for the detection of this virus no commercially available
laboratory test is reported.
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Infant microcephaly and GBS are the major clinical com-
plications associated with ZIKV infections.
5.1. Microcephaly
Microcephaly as a complication of ZKIAV infection was
noticed in year 2013 [20]. During the recent outbreak in Brazil,
microcephaly cases attained unprecedented attention [51]. That
was mainly because, within the few months of ﬁrst ZIKV case,
a remarkable increase in the infant microcephaly cases was
recorded. Yet, general perception about the magnitude of this
problem could be misleading. In fact, till the month of
February, health ofﬁcials in Brazil scrutinized more than
1113 cases of suspected microcephaly, out of which 404
were conﬁrmed as microcephaly, and based on concrete
evidence just 17 cases were linked to ZIKV infection.
Overall, after the ﬁrst report of ZIKV infection in Brazil,
total numbers of suspected microcephaly cases were 3670 till
the month of January 2016 [51]. Hence, it seems plausible,
that due to the stringent scrutiny of microcephaly cases in
the country otherwise unreported cases were also reported.
Notably, RNA of ZIKV has been detected in the samples of
brain tissues, placenta and amniotic ﬂuid. However,
assigning exact number of microcephaly cases to ZIKV
infection at this time point remains quite trivial. In this
regard, Ministry of Health in Brazil has recently mounted its
efforts by setting large control studies. Despite these efforts,
epidemiological data alone may not sufﬁce a strong evidence
for the clinical association of microcephaly with ZIKV
infection. Thus quest for the concrete scientiﬁc evidence to
solve this issue requires scientiﬁc investigations based on
relevant infection models. Yet, the toughest part of the riddle
is the vast majority of the mothers infected with ZIKV gave
birth to healthy babies.
5.2. Guillain–Barre´ syndrome
GBS is characterized as a rapid-onset of muscle weakness
that occurs due to the damage to peripheral nerves caused by the
immune system. During the last outbreak in French Polynesia,
total 8000 cases of suspected ZIKV infections were reported,
out of which 396 were conﬁrmed by PCR. Neurological com-
plications were reported in 70 cases and 38 were conﬁrmed as
GBS. Other, 25 cases of neurological complications were
characterized as encephalitis, meningoencephalitis, paresthesias,
facial paralysis and myelitis [52]. In Brazil, similar to increase in
microcephaly cases during the episode of ZIKV infection, sharp
increase in GBS cases was also recorded [53]. Yet again, exact
numbers of GBS cases caused by ZIKV during this outbreak
remains to be established, however, available data strongly
endorses a link between GBS and ZIKV infections.
6. Treatment of ZIKV infection
Supportive therapy is recommended for the patients who may
develop symptomatic disease and it relies solely on severity of
the symptoms. Patient care includes proper hydration, moni-
toring for possible coagulopathy and multiple organ failure.
Intensive care is recommended for the patients depicting seriousconditions, like showing signs of coagulopathy, tachycardia,
hypotension and renal dysfunction. Patients with neurological
complications such as GBS, require hospitalization. In-case of
suspected patients in pregnancy phase, sonography is recom-
mended to monitor the proper fetal growth and particularly to
avoid complications of infant microcephaly. Non-steroidal anti-
inﬂammatory drugs and aspirin can be recommended for the
treatment, such medications should be avoided in case of
concomitant infection with dengue fever virus. No antiviral
treatments are suggested for ZIKV infection.
7. Prevention and control
In order to combat ZIKV infection, public awareness should
remain the top priority, particularly information about breeding
grounds of the mosquitoes, such as stagnant water ponds, un-
attended furniture, polythene bags in rain, old automobile tires,
risk factors, associated with gardening and plants containing
water. Moreover, use of mosquito nets should be highly
encouraged. At the governmental level, policy makers should
address emerging threats of vector-borne infections particularly
in vulnerable societies. Current scenario of global climate
change must be given serious considerations. Planning in
advance and infrastructure developments, prior to the occurrence
of the outbreaks are key measures which are mostly ignored in
the developing countries. In order to effectively counter ZIKV or
other mosquito-borne diseases, a collective sense of re-
sponsibility must prevail in societies, both at public and
governmental level. Recent studies endorsed transmission of
ZIKV via sexual contact which demands more efforts regarding
public awareness. Effective vector control strategies and quar-
antine measures are necessary to minimize geographical spread
of the virus.
8. Conclusions
Recent episodes of the infections caused by ZIKV in South-
American territory highlighted epidemiological importance of
this virus, which now demands a new level of vigilance and
resource allocation to minimize the risk of future outbreaks. In
terms of its magnitude, current outbreak was unprecedented
that stresses the need for preparedness and development of
effective strategies for the vector control. In addition, appro-
priate diagnostic tools for ZIKV identiﬁcation are urgently
needed, efforts related to scientiﬁc research should be mounted
to establish a clear link between ZIKV infections and suspected
clinical complications. Current evidence regarding sexual
transmission and transfusion transmitted infections of ZIKV
needs enhanced public awareness. To avoid the risk of trans-
fusion transmitted infections blood screening protocols must be
updated particularly in high risk areas. In short, a collaborative
approach at the global level should be given high priority to
minimize the spread of the vector-borne viral diseases like
ZIKV infection. Developing countries should be encouraged to
combine efforts for the vigilant and well-structured national
surveillance programs for monitoring infectious diseases on
regular basis.
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